Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Studio di Diagnostica Nucleare (SDN), 80143 Naples, Italy.
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16570-5. doi: 10.1073/pnas.1207917109. Epub 2012 Sep 24.
MicroRNAs (miRNAs) have an important role in the development of chemosensitivity or chemoresistance in different types of cancer. Activation of the ERK1/2 pathway is a major determinant of diverse cellular processes and cancer development and is responsible for the transcription of several important miRNAs. Here we show a link between the ERK1/2 pathway and BIM expression through miR-494. We blocked ERK1/2 nuclear activity through the overexpression of an ERK1/2 natural interactor, the protein PED/PEA15, and we performed a microRNA expression profile. miR-494 was the most down-regulated microRNA after ERK1/2 inactivation. Moreover, we found that miR-494 induced Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) resistance in non-small-cell lung cancer (NSCLC) through the down-modulation of BIM. Elucidation of this undiscovered ERK1/2 pathway that regulates apoptosis and cell proliferation through miR-494 in NSCLC will greatly enhance our understanding of the mechanisms responsible for TRAIL resistance and will provide an additional arm for the development of anticancer therapies.
MicroRNAs (miRNAs) 在不同类型癌症的化疗敏感性或耐药性发展中具有重要作用。ERK1/2 通路的激活是多种细胞过程和癌症发展的主要决定因素,负责几个重要 miRNAs 的转录。在这里,我们通过 miR-494 显示了 ERK1/2 通路和 BIM 表达之间的联系。我们通过过表达 ERK1/2 的天然相互作用蛋白 PED/PEA15 来阻断 ERK1/2 的核活性,并进行了 microRNA 表达谱分析。miR-494 是 ERK1/2 失活后下调最明显的 microRNA。此外,我们发现 miR-494 通过下调 BIM 诱导非小细胞肺癌 (NSCLC) 对肿瘤坏死因子 (TNF)-相关凋亡诱导配体 (TRAIL) 的耐药性。阐明这条调节 NSCLC 细胞凋亡和增殖的未被发现的 ERK1/2 通路,将极大地增强我们对 TRAIL 耐药机制的理解,并为开发抗癌疗法提供另一种手段。